Skip to main content

MitoChem Therapeutics

Charleston, United States

MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.

$200K raised
Sep 2022
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about MitoChem Therapeutics

How much funding has MitoChem Therapeutics raised?
MitoChem Therapeutics has raised $200K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2022.
Who are MitoChem Therapeutics's investors?
MitoChem Therapeutics's investors include South Carolina Research Authority, Foundation Fighting Blindness, SC Launch, Inc., Ichor Life Sciences.
Where is MitoChem Therapeutics headquartered?
MitoChem Therapeutics is headquartered in Charleston, United States.
What does MitoChem Therapeutics do?
MitoChem Therapeutics develops treatments to address the effects of mitochondrial dysfunction in neurodegenerative, aging, and disease.
What stage is MitoChem Therapeutics at?
MitoChem Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"MitoChem Therapeutics — Funding & Investors." VCBacked, September 6, 2022, https://www.vcbacked.co/company/mitochem-therapeutics. Accessed July 1, 2026.
APA
VCBacked. (2022). MitoChem Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/mitochem-therapeutics
Wikipedia (cite web)
{{cite web |title=MitoChem Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mitochem-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .